Chronic obstructive pulmonary disease, or COPD, is a long-term lung disease that causes ongoing inflammation and irreversible damage to lung tissues. This damage affects both the structure and function of the lungs, leading to serious breathing problems. COPD is a major health challenge worldwide, causing significant illness and death. Although current treatments can ease symptoms, they do not repair the damage that COPD causes to the lungs.
Because of these limitations, researchers have turned to regenerative medicine and the exciting potential of stem cell therapy to find better treatments. Stem cells are special cells with the ability to renew themselves and transform into different types of cells. Scientists are exploring how stem cells could help repair damaged lung tissue and improve lung function in people living with COPD.
How COPD Develops and Damages the Lungs Over Time
COPD is caused mainly by long-term exposure to harmful substances such as cigarette smoke, air pollution, and certain chemicals. In some cases, a genetic condition called α1-antitrypsin deficiency can also increase the risk. These factors lead to chronic inflammation, destruction of lung tissue, and narrowing of the airways.
Two common forms of COPD are chronic bronchitis and emphysema. Chronic bronchitis involves inflammation of the lining of the airways, which leads to excessive mucus production and swelling. This mucus buildup blocks airflow, making it difficult to breathe. Emphysema, on the other hand, damages the tiny air sacs called alveoli, which are essential for oxygen exchange. This damage causes the air sacs to enlarge and lose elasticity, reducing the lungs’ ability to transfer oxygen into the bloodstream.
As COPD worsens, patients experience increasing difficulty in breathing, often feeling breathless even during mild activity. This progressive lung damage also leads to other complications like airway hyperresponsiveness and overlapping lung diseases.
Current Treatments and Their Limitations
Today, there is no cure for COPD. The main treatments focus on controlling symptoms, reducing inflammation, and improving quality of life. Quitting smoking is the most important step to slow disease progression. Other treatments include medications such as bronchodilators and steroids, oxygen therapy, vaccinations to prevent infections, and pulmonary rehabilitation to help patients breathe better.
While these treatments can relieve symptoms and improve lung function temporarily, they do not stop or reverse the underlying damage to lung tissue. This means the disease continues to progress over time despite therapy. Because of this, scientists are urgently seeking new approaches that can restore lung function by repairing or regenerating damaged lung tissues.
Stem Cells: A Promising Avenue for Lung Repair
Stem cells are unique cells capable of dividing endlessly and turning into different types of mature cells. This remarkable ability makes them an ideal candidate for regenerative medicine, which aims to heal damaged organs and tissues. In COPD, stem cells might be able to replace destroyed lung cells, reduce inflammation, and promote the natural repair process.
There are several types of stem cells under investigation for COPD treatment. Embryonic stem cells (ESCs) are derived from early-stage embryos and can develop into almost any cell type. Induced pluripotent stem cells (iPSCs) are adult cells reprogrammed to an embryonic-like state, also able to become many different cell types. Adult stem cells exist in various tissues and serve as the body’s repair system. Among adult stem cells, mesenchymal stem cells (MSCs) are widely studied for lung repair.
Comparing Different Stem Cell Types
Lung progenitor cells are specialized to the lungs but are rare and difficult to obtain. MSCs, which can be harvested from bone marrow, fat tissue, and other sources, are easier to collect and have lower chances of immune rejection and tumor formation. MSCs also have strong anti-inflammatory properties, making them attractive for treating inflammatory lung diseases like COPD.
Despite these advantages, MSCs have some challenges, such as variability in their behavior and the risk of aging or senescence, which could limit their effectiveness. Researchers continue to study ways to enhance the safety and efficacy of MSC-based treatments, including combining them with other therapies or using supportive materials that help stem cells survive and integrate into lung tissue.
How Mesenchymal Stem Cells Help Repair Lung Damage
MSCs have been tested in animal models of lung injury with encouraging results. They appear to help repair lung tissue by several mechanisms. One is cell replacement: MSCs can transform into lung-specific cells and replace damaged cells, improving the lung’s structure and function. Another way is through paracrine effects, meaning MSCs release various substances that encourage the body’s own repair systems.
Studies show that when MSCs are introduced into the lungs, they do not simply settle there in large numbers but instead release molecules that reduce inflammation, attract native stem cells, and stimulate regeneration. These molecules include anti-inflammatory factors and growth factors that help heal damaged tissue and prevent cell death.
In animal models, MSC treatment has reduced lung damage caused by cigarette smoke and improved lung function. MSC-derived secretions, like conditioned medium (the fluid containing MSC-released factors) and extracellular vesicles (tiny particles carrying proteins and genetic material), have also shown protective and reparative effects in lung injury studies. These findings suggest that MSCs help repair lung tissue both by becoming new lung cells and by signaling the body to heal itself.
What Stem Cell Advances Mean for COPD Treatment
While the research on stem cell therapies for COPD is still largely in the preclinical stage, it holds great promise for the future. MSCs in particular offer a potentially safe and effective approach to slow down, stop, or even reverse lung damage. Future treatments might involve infusions of MSCs, the use of MSC secretions, or combinations with other treatments to maximize lung repair.
Scientists are also exploring ways to improve stem cell therapies, such as by pre-conditioning MSCs before transplanting them or combining them with gene therapy. New techniques involving 3D scaffolds and biomaterials might help stem cells survive and work better inside damaged lungs.
A New Frontier in COPD Treatment
COPD remains a serious and progressive disease with limited treatment options. Although current therapies manage symptoms, they do not restore lost lung function. Regenerative medicine and stem cell therapy, especially using mesenchymal stem cells, represent a hopeful new direction. These therapies aim to repair lung damage and improve lung function by leveraging the natural ability of stem cells to regenerate tissue and reduce inflammation.
Continued research and clinical trials are essential to fully understand how best to use stem cells for COPD and to ensure these treatments are safe and effective. The day when stem cell therapy becomes a standard treatment for COPD may be on the horizon, potentially offering relief and improved quality of life for millions of patients worldwide.
Source: Lai, S., Guo, Z. Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option. Stem Cell Res Ther 15, 312 (2024). https://doi.org/10.1186/s13287-024-03940-9
St. Petersburg, Florida
